Publication | Closed Access

Efficacy and Safety of Subcutaneous Vivaglobin® Replacement Therapy in Previously Untreated Patients with Primary Immunodeficiency: A Prospective, Multicenter Study

Primary ImmunodeficiencyTreatment And PreventionImmunodeficienciesImmunologyClinical TrialsHematologyPharmacotherapyHivMulticenter StudyMedicineHealth Sciences